39 results on '"Hernández-Rivas, J.M."'
Search Results
2. NEMHESYS - European perspective on the implementation of next-generation sequencing into clinical diagnostics
3. Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting
4. Estudio prospectivo, de seguimiento en pacientes con enfermedad de Gaucher Tipo 1 que reciben tratamiento con CERDELGA®. Proyecto TRAZELGA
5. La secuenciación masiva dirigida revela que los pacientes con leucemia linfática crónica y reordenamiento de igh presentan mutaciones en los genes POT1, EGR2, BRAF, IGLL5 Y MGA
6. PF182 CLINICOBIOLOGIC CHARACTERISTICS AND OUTCOME OF ELDERLY FRAIL PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA INCLUDED IN A SPECIFIC PROTOCOL (ALL-07FRAIL)
7. PF170 ETV6/RUNX1 FUSION GENE ABROGATION DECREASE THE ONCOGENIC POTENCIAL OF TUMORS CELLS IN A PRECLINICAL MODEL OF ACUTE LYMPHOBLASTIC LEUKEMIA
8. PB1654 COMPREHENSIVE AND SEQUENTIAL GENETIC ANALYSIS OF B-CELL ALL REVEALS AN ARRAY OF CHANGES WITH A HIGH INCIDENCE OF TP53 MUTATIONS AND IKZF1 DELETIONS
9. S896 SYNTHETIC LETHAL EFFECTS OF DUAL BCR AND PARP INHIBITION IN PROLIFERATIVE DEL(11Q) CLL CELLS IN THE PRESENCE OF STROMAL STIMULATION
10. PF357 A NOVEL REFINED PROGNOSTIC MODEL FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS COMBINING IGH TRANSLOCATIONS AND NEXT-GENERATION SEQUENCING
11. PF533 MUTATIONS ON COHESIN COMPLEX ARE ASSOCIATED TO A POOR PROGNOSIS IN LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS
12. Two novel variants of the ABCG5 gene cause xanthelasmas and macrothrombocytopenia: a brief review of hematologic abnormalities of sitosterolemia
13. 98 - Azacitidine Improves Outcome in High Risk MDS Patients with Chromosome 7 Abnormalities: Retrospective Comparison of GESMD and GFM Registries
14. 41 - Chronic GVHD Could Ameliorate the Impact of Adverse Somatic Mutations in Patients with Myelodysplastic Syndromes and Hematopoietic Stem Cell Transplantation
15. Uniparental disomy causes deficiencies of vitamin K‐dependent proteins
16. P029 Prognostic relevance of specific chromosomal abnormalities in chronic myelomonocytic leukemia
17. P030 Prognostic impact on survival of an unsuccessful conventional cytogenetic study in patients with myelodysplastic syndromes (MDS)
18. C005 Prognostic impact of the proportion of aberrant metaphases in patients with a primary myelodysplastic syndrome
19. Mutations in DNA Methylation Pathway and Number of Driver Mutations Predict Response to Azacitidine in Myelodysplastic Syndromes
20. Chronic GVHD Could Ameliorate the Impact of Adverse Somatic Mutations in Patients with Myelodysplastic Syndromes and Hematopoietic Stem Cell Transplantation
21. Azacitidine Improves Outcome in High Risk MDS Patients with Chromosome 7 Abnormalities: Retrospective Comparison of GESMD and GFM Registries
22. Mutational Status of Mesenchymal Stem Cell in Myelodysplastic Syndromes Patients
23. Mutational and Clonal Dynamics During Progression from MDS to SAML by Whole-Exome and Targeted-Deep Sequencing
24. 213 AZACITIDINE (AZA) IN HIGHER RISK MDS PATIENTS WITH CHROMOSOME 7 ABNORMALITIES (ABN 7): RESULTS OF A RETROSPECTIVE STUDY FROM THE GFM AND GESMD REGISTRIES
25. 206 IMPACT OF TP53 MUTATION ON OUTCOME OF MDS PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT (HSCT). GESMD STUDY
26. 171 A TWO-STEP APPROACH FOR THE ANALYSIS OF SPLICING GENES IN MYELODYSPLASTIC SYNDROMES WITH RING SIDEROBLASTS
27. 196 - Mutational Status of Mesenchymal Stem Cell in Myelodysplastic Syndromes Patients
28. 97 - Mutations in DNA Methylation Pathway and Number of Driver Mutations Predict Response to Azacitidine in Myelodysplastic Syndromes
29. 116 - Modifications in Mutational Landscape in Patients with Lower Risk MDS without 5Q Deletion Receiving Azacitidine Are Correlated with Clinical Response
30. 87 - Mutational and Clonal Dynamics During Progression from MDS to SAML by Whole-Exome and Targeted-Deep Sequencing
31. P-235 RCMD patients have an abnormal angiogenesis related to endoglin
32. P-054 Application of array-based karyotyping as a complementary tool in the diagnosis of myelodysplastic syndromes and related myeloid neoplasms
33. P-017 Genetic alterations of the epigenetic pathways on MDS patients with a 5q deletion drive specific methylation signatures
34. Two novel variants of the ABCG5gene cause xanthelasmas and macrothrombocytopenia: a brief review of hematologic abnormalities of sitosterolemia
35. 244 MYELOFIBROSIS (MF) AS A PROGNOSTIC TOOL FOR OVERALL SURVIVAL IN MYELODYSPLASTIC SYNDROMES: A PROSPECTIVE EVALUATION INCLUDING MUTATIONAL ANALYSIS BY NEXT GENERATION SEQUENCING (NGS)
36. 162 Gastric Adenocarcinomas.: methylation and deletions of DNA mismatch repair in tumoural cells and normal gastric mucosa cells
37. 1619P - Mutational Analysis of Circulating Dna and Cells in Patients with Metastatic Colorectal Cancer
38. Técnicas de estudio cromosómico. Citogenética convencional, hibridación in situ fluorescente y sus variedades. Aplicaciones clínicas
39. 160 High-grade gliomas: epigenetic and genetic analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.